MA04.01 Cemiplimab, a Human Monoclonal Anti-Pd-1, Alone or in Combination With Radiotherapy: Phase 1 NSCLC Expansion Cohorts
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.340
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV